The article notes this particular healthcare fund made billions of dollars in profit for the year and one of the parties interviewed speculates that this individual's care would represent a few minutes of that.

The gastroenterologist is not the expensive part, either, the expensive part was the manufacturing process for the drug. It would be super cool to invest the billions of profit for this insurance company into developing more efficient ways to produce this category of drug. Alas,

Instead we are investing in finding the most underhanded ways possible to deny medical care for each patient, all the while pretending we are not making medical decisions for them.